Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Jang v. Boston Scientific Corporation, No. 16-1275 (Fed. Cir. Sept. 29, 2017)

Affirmed
Non-Infringement JMOL / Post-Trial Doctrine of Equivalents
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1275
Also Docketed
No. 16-1575 (consolidated; same document)
Decided
September 29, 2017
Judge
Chen, J.
Document
Precedential Opinion
Length
25 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

This dispute between G. David Jang, M.D. (Dr. Jang) and Boston Scientific Corp. and Scimed Life Systems, Inc. (collectively, BSC), more than a decade old, returns to us for a fourth time . In the latest appeal of this case invol v- ing U.S. Patent No. 5,922,021 ( ʼ021 Pate nt) and BSC’s sales of several coronary stents (collectively , Express stent), Dr.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error